MTMR4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.757000E-01
Normal-vs-Stage2
3.569800E-01
Normal-vs-Stage3
2.294800E-01
Normal-vs-Stage4
2.708000E-01
Stage1-vs-Stage2
8.844400E-01
Stage1-vs-Stage3
9.551700E-02
Stage1-vs-Stage4
8.435600E-01
Stage2-vs-Stage3
2.655600E-02
Stage2-vs-Stage4
6.792200E-01
Stage3-vs-Stage4
4.328100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.609600E-01
Normal-vs-AfricanAmerican
3.977400E-01
Normal-vs-Asian
3.052800E-01
Caucasian-vs-AfricanAmerican
6.406400E-01
Caucasian-vs-Asian
3.364400E-02
AfricanAmerican-vs-Asian
6.627900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.658400E-01
Normal-vs-Female
3.524000E-01
Male-vs-Female
5.636400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.061200E-01
Normal-vs-Age(41-60Yrs)
3.848600E-01
Normal-vs-Age(61-80Yrs)
3.481800E-01
Normal-vs-Age(81-100Yrs)
3.367600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.676200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.247600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.043600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.314990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.198600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.782000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.092800E-01
Normal-vs-Daily Drinker
3.059600E-01
Normal-vs-Weekly Drinker
3.768000E-01
Normal-vs-Occasional Drinker
3.977400E-01
Normal-vs-Social Drinker
4.236000E-01
Non Drinker-vs-Daily Drinker
9.104000E-01
Non Drinker-vs-Weekly Drinker
2.038400E-01
Non Drinker-vs-Occasional Drinker
1.286790E-01
Non Drinker-vs-Social Drinker
8.062800E-03
Daily Drinker-vs-Weekly Drinker
2.043000E-01
Daily Drinker-vs-Occasional Drinker
1.180560E-01
Daily Drinker-vs-Social Drinker
6.915100E-03
Weekly Drinker-vs-Occasional Drinker
7.869400E-01
Weekly Drinker-vs-Social Drinker
4.688000E-01
Occasional Drinker-vs-Social Drinker
6.647400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.540200E-02
Normal-vs-Grade 2
4.229700E-02
Normal-vs-Grade 3
3.540400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.726610E-01
Grade 1-vs-Grade 3
8.290600E-01
Grade 1-vs-Grade 4
9.540200E-02
Grade 2-vs-Grade 3
7.430200E-02
Grade 2-vs-Grade 4
4.229700E-02
Grade 3-vs-Grade 4
3.540400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.366400E-01
Normal-vs-NonDiabetic
3.494800E-01
Diabetic-vs-NonDiabetic
5.968000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.207800E-01
Normal-vs-NoPancreatitis
3.484600E-01
Pancreatitis-vs-NoPancreatitis
4.761600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.699000E-01
Normal-vs-N1
3.533600E-01
N0-vs-N1
5.494200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.620400E-01
Normal-vs-TP53-NonMutant
4.589400E-01
TP53-Mutant-vs-TP53-NonMutant
1.069620E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
